Diazepam versus clobazam for intermittent prophylaxis of febrile seizures

Nahid Khosroshahi1, Fatemeh Faramarzi, Payman Salamati

  • 1Division of neurology, Department of pediatrics, Bahrami Children Hospital, Tehran University of Medical Sciences, Tehran, Iran. Nahidkhosroshahi@yahoo.com

Insights

Intermittent clobazam is as effective as diazepam for preventing febrile seizure recurrence but causes fewer side effects like drowsiness. This finding suggests clobazam may be a preferred option for managing febrile seizures in children.

Area of Science:

  • Pediatric Neurology
  • Clinical Pharmacology

Background:

  • Febrile seizures are common in young children.
  • Preventing seizure recurrence is crucial to minimize potential neurological impact.

Purpose of the Study:

  • To compare the efficacy of intermittent clobazam versus diazepam in preventing febrile seizure recurrence.
  • To assess and compare the adverse effects of clobazam and diazepam therapies.

Main Methods:

  • A prospective randomized controlled trial involving neurologically normal children aged 6 months to 5 years with a history of simple febrile seizures.
  • Patients received either oral clobazam (37 cases) or diazepam (35 cases) during febrile episodes, with medication use advised for the first 48 hours of fever.
  • Monitoring for seizure recurrence and drug adverse effects was conducted over a 12-month follow-up period.

Main Results:

  • Seizure recurrence occurred in 1.7% of the clobazam group and 3.1% of the diazepam group (P=0.474).
  • Drowsiness and sedation were significantly more frequent in the diazepam group (54%) compared to the clobazam group (14.2%) (P=0.0001).

Conclusions:

  • Intermittent clobazam therapy demonstrates comparable efficacy to diazepam in preventing febrile seizure recurrence.
  • Clobazam is associated with significantly lower rates of adverse effects, particularly drowsiness and sedation, making it a potentially more favorable treatment option.
Abstract

Related Concept Videos

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
Antiepileptic Drugs: Sodium Channel Blockers01:08

Antiepileptic Drugs: Sodium Channel Blockers

Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Antiepileptic Drugs: Calcium Channel Blockers01:17

Antiepileptic Drugs: Calcium Channel Blockers

Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Anxiolytic Drugs: Benzodiazepines and Buspirone01:29

Anxiolytic Drugs: Benzodiazepines and Buspirone

Benzodiazepines are a class of anxiolytic drugs known for their rapid efficacy and high therapeutic-to-lethal dose ratio, but with a potential risk of drug dependence. These drugs are lipophilic, allowing for rapid absorption after oral administration, eventually reaching the central nervous system (CNS). Once in the CNS, benzodiazepines bind to the allosteric site of the GABAA receptor. This binding enhances the inhibitory effects of the neurotransmitter GABA. By doing so, they prevent...